Intratubular Cytoplasmic AL Amyloidosis Associated with Amyloidogenic and Crystalline Light Chain Cast Nephropathy
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Bridoux F, Leung N, Belmouaz M, Royal V, Ronco P, Nasr S
. Management of acute kidney injury in symptomatic multiple myeloma. Kidney Int. 2021; 99(3):570-580.
DOI: 10.1016/j.kint.2020.11.010.
View
2.
Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, DAgati V
. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol. 2018; 15(1):45-59.
PMC: 7136169.
DOI: 10.1038/s41581-018-0077-4.
View
3.
Said S, Rocha A, Valeri A, Paueksakon P, Dasari S, Theis J
. The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis. Kidney Int. 2021; 101(1):152-163.
DOI: 10.1016/j.kint.2021.10.019.
View
4.
Royal V, Leung N, Troyanov S, Nasr S, Ecotiere L, LeBlanc R
. Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study. Blood. 2020; 135(21):1833-1846.
PMC: 7243151.
DOI: 10.1182/blood.2019003807.
View
5.
Nasr S, Alobeid B, Otrakji J, Markowitz G
. Myeloma cast nephropathy, direct renal infiltration by myeloma, and renal extramedullary hematopoiesis. Kidney Int. 2008; 73(4):517-8.
DOI: 10.1038/sj.ki.5002416.
View